CCND1 and chromophobe renal cell carcinoma: There are some reports in the literature describing the involvement of cyclin D1 and Pax2 in human CRCC tumorigenesis [32,33] and for Pax2 in responses to therapies, but not for the SHH ligand, Gli1 and Lim1.